Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET.
作者： Yoshihiro Nishiyama , Yuka Yamamoto , Kenji Kanenishi , Masami Ohno , Toshiyuki Hata
DOI: 10.1007/S00259-007-0627-7
关键词:
摘要: Purpose We retrospectively evaluated the ability of FDG PET to predict response primary tumor chemotherapy or chemoradiotherapy in patients with gynecological cancer.
springer.com
sci-hub.se 参考文章(23)
A. Dimitrakopoulou, Uwe Haberkorn, L. G. Strauss, G. Van Kaick, F. Oberdorfer, H. Ostertag, J. Romahn, R. Engenhart, PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. The Journal of Nuclear Medicine. ,vol. 32, pp. 1485- 1490 ,(1991)
Yuji Nakamoto, Avraham Eisbruch, Eric D. Achtyes, Yoshifumi Sugawara, Kevin R. Reynolds, Carolyn M. Johnston, Richard L. Wahl, Prognostic Value of Positron Emission Tomography Using F-18-Fluorodeoxyglucose in Patients with Cervical Cancer Undergoing Radiotherapy Gynecologic Oncology. ,vol. 84, pp. 289- 295 ,(2002) , 10.1006/GYNO.2001.6504
Peter E. Schwartz, Thomas J. Rutherford, Joseph T. Chambers, Ernest I. Kohorn, Robert P. Thiel, Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: Long-Term Survival Gynecologic Oncology. ,vol. 72, pp. 93- 99 ,(1999) , 10.1006/GYNO.1998.5236
Marinke Westerterp, Henderik L. van Westreenen, Johannes B. Reitsma, Otto S. Hoekstra, Jaap Stoker, Paul Fockens, Pieter L. Jager, Berthe L. F. Van Eck-Smit, John T. M. Plukker, J. Jan B. van Lanschot, Gerrit W. Sloof, Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy. Systematic review Radiology. ,vol. 236, pp. 841- 851 ,(2005) , 10.1148/RADIOL.2363041042
Y.M. Chan, T.Y. Ng, Hextan Y.S. Ngan, L.C. Wong, Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study. Gynecologic Oncology. ,vol. 88, pp. 9- 16 ,(2003) , 10.1006/GYNO.2002.6849
Tzu-Chen Yen, Chyong-Huey Lai, Positron emission tomography in gynecologic cancer. Seminars in Nuclear Medicine. ,vol. 36, pp. 93- 104 ,(2006) , 10.1053/J.SEMNUCLMED.2005.08.004
D. Allen, K. Narayan, Managing advanced-stage cervical cancer. Best Practice & Research in Clinical Obstetrics & Gynaecology. ,vol. 19, pp. 591- 609 ,(2005) , 10.1016/J.BPOBGYN.2005.03.001
Distefano Mariagrazia, Fagotti Anna, Ferrandina Gabriella, Fanfani Francesco, Smaniotto Daniela, D'Agostino Giuseppe, Morganti Alessio, Scambia Giovanni, Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecologic Oncology. ,vol. 99, ,(2005) , 10.1016/J.YGYNO.2005.07.074
Yan Ansquer, Eric Leblanc, Krichna Clough, Philippe Morice, Jacques Dauplat, Patrice Mathevet, Catherine Lhomm�, Christophe Scherer, Jean-Dominique Tigaud, Mehdi Benchaib, Emmanuelle Fourme, Damiene Castaigne, Denis Querleu, Daniel Dargent, Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study. Cancer. ,vol. 91, pp. 2329- 2334 ,(2001) , 10.1002/1097-0142(20010615)91:12<2329::AID-CNCR1265>3.0.CO;2-U
Yuka Yamamoto, Yoshihiro Nishiyama, Toshihide Monden, Yasuhiro Sasakawa, Motoomi Ohkawa, Masashi Gotoh, Kotaro Kameyama, Reiji Haba, Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 33, pp. 140- 147 ,(2006) , 10.1007/S00259-005-1878-9